FREE ELECTRONIC LIBRARY - Dissertations, online materials

Pages:   || 2 | 3 |

«Supported by: GS1 Healthcare Conference Toronto, Canada, 17-19 June 2008 2 GS1 Healthcare – Improving patient safety worldwide GS1 Healthcare ...»

-- [ Page 1 ] --

GS1 Healthcare Conference

17-19 June 2008

Le Méridien King Edward Hotel

Toronto, Ontario, Canada

Supported by:

GS1 Healthcare Conference

Toronto, Canada, 17-19 June 2008


GS1 Healthcare – Improving patient safety worldwide

GS1 Healthcare Conference

Toronto, Canada, 17-19 June 2008

Dear Participant,

Welcome to the GS1 Healthcare Conference in Toronto!

Global standards in the Healthcare supply chain: are we there yet? We have already

gone a long way, but there is still a long journey ahead. The coming 18 months will be important to continue to lay the foundation for the adoption of global supply chain standards in Healthcare: continue the development of global standards to meet Healthcare specific needs, intensify our efforts advocating global harmonisation, and leverage the network of GS1 Member Organisations to educate local Healthcare communities about GS1 Standards. Also beyond 2009, we anticipate a lengthy adoption process, different from one country to another country and from one stakeholder to another stakeholder, but the benefits in terms of patient safety and efficiency will be substantial from day one for those adopting the standards.

To achieve all of this, we need a broad representation from all Healthcare supply chain stakeholders. Many leading manufacturers have joined the recently formed GS1 Healthcare, the global Healthcare user group merging the former GS1 HUG and EPCglobal HLS. We are also happy that a number of Healthcare providers and GPO’s have become a voting member of GS1 Healthcare, including the Hong Kong Hospital Authority, 17 French university hospitals, Vinzenz Gruppe (Vienna, Austria), Erasmus MC and UMC Groningen (the Netherlands), Comparatio University Hospital Group (Germany), Premier (USA), and University of Kentucky Healthcare (USA). Nevertheless, we encourage more participation in GS1 Healthcare, either at global level or at local level, to drive GS1 Healthcare activities across the globe.

GS1 Healthcare Conferences always provide a unique platform for Healthcare supply chain stakeholders to meet and to advance global standards. The high-quality programme will provide you with a full update on the most important aspects of global standards in the Healthcare supply chain. The conference will also serve the global standards development work through various work team sessions. This fruitful exchange of knowledge and experience aims at further developing GS1 Standards to meet Healthcare specific needs to improve patient safety worldwide and to increase supply chain efficiency. We therefore encourage you to actively participate in these sessions.

Special thanks to GS1 Canada for their support in organising this conference.

Thank you for participating to the GS1 Healthcare Conference. We hope you will have an interesting, challenging and educational few days.

Best regards, Michel van der Heijden President Healthcare, GS1 Global Office

–  –  –

Restaurants La Maquette, a restaurant renowned for its romantic atmosphere and sumptuous culinary delights. Year after year La Maquette has been nominated in numerous categories including: Most Romantic, Best Venue, Best Food, Best Service, Best Ambience and Best Desserts by Where Magazine's Toronto voters. Come enjoy the refined elegance of a historically designated landmark overlooking the Toronto Sculpture Garden & St. James Cathedral.

Bier Market, located in one of Toronto's most historic districts - on the city's original waterfront promenade - the Esplanade Bier Markt remains a place to see and be seen.

Beginning with a selection of over 100 brands of beer from 24 countries, the European brasserie's culinary commitment is defined by season to ensure exceptional quality. Chic and dynamic modern design compliment the stay as do friendly and knowledgeable staff.

The Keg Steakhouse, great Keg steaks, a casual atmosphere, and friendly, knowledgeable service are the proud trademarks of The Keg Steakhouse & Bar.

–  –  –

Plenary Speakers Prof. Masanori AKIYAMA is visiting professor at the Massachusetts Institute of Technology Sloan School of Management and the Tokyo Medical University as well as assistant professor at Keio University School of Medicine and the Hamamatsu University School of Medicine. After his M.D. degree at the university of Tokushima he was working in the fields of urology and pathology before concentrating more on the field of Medical Informatics.

From 1999 to 2002 he held a position in the Ministry of Health and Welfare in the Department of National Hospitals policy medical treatment section.

Afterwards he joined the National Institute of Public Health as associated professor.

Prof. Masanori Akiyama is the director of the Japan association for medical informatics.

Paul ASHFORD has worked as a Clinical Scientist in the field of Transfusion Medicine for 30 years, and has been involved in providing IT solutions for over 20 years. For several years he was Chairman of the UK Blood Services Standing Advisory Committee on Information Technology and a member of the UK Blood Services Professional Advisory Committee.

Paul has been involved in the development of the ISBT 128 information standard since 1999. He was appointed Executive Director of ICCBBA, the organization responsible for the management, technical development and promotion of ISBT 128, in 2005.

He is currently Chairman of the International Cellular Therapy Coding and Labeling Advisory Group and a member of the International Society for Blood Transfusion Working Party on Information Technology.

Bettina BARTZ is Senior Project Manager of GS1 Germany and has several years of experience in healthcare. Since October 2006, she is responsible for all GS1 Germany activities in the healthcare sector. One of her accomplishments was the establishment of the national GS1 Healthcare Germany initiative with appropriate specialized groups.

Before Gs1 Germany, Bettina worked for a pharmaceutical manufacturer as Key Account Manager. She also worked several years on different logistics projects wit an IT Solution Provider.

She holds a Masters degree in Project Management and Marketing. She has written her master thesis about “Efficient Consumer Response focused on the healthcare OTC market” with an excellent mark.

10 GS1 Healthcare – Improving patient safety worldwide GS1 Healthcare Conference Toronto, Canada, 17-19 June 2008 Lisa BELZAK works with Division of Immunization Programs at the Public Health Agency of Canada where she is the Head of the Monitoring and Assessment Unit. She is also the Federal Co Chair of the the Automated Identification of Vaccine Products Advisory Committee and the Canadian Immunization Registry Network.

Ms. Belzak has been actively involved with GS1 since 2004 as a member of the Vaccine and Biologics Working Group and the former HUG. Through her work at the Agency and GS1, she has advocated for the voluntary placement of bar codes with variable data on the primary packages of vaccines to improve the accuracy and completeness of electronic immunization records and the safe use of vaccines.

Elizabeth CALLAGHAN is presently Acting Director of the Division of Blood Applications. Ms. Callaghan joined FDA 16 years ago as a reviewer for Blood and Blood Components. During her tenure at CBER she has also held the position as the Program Manager for the Blood Action Plan and Special Assistant to the Associate Director for Policy in the Immediate Office of the Director Prior to joining the FDA Ms. Callaghan was a Blood Bank Manager for several hospitals in New York State and was instrumental in starting up private 2 frozen blood repositories and 2 private full service clinical laboratories.

Ms. Callaghan received her BS in Medical Technology from SUNY at Stony Brook and her MS from St John’s University in Queens, NY.

Dr. Ann CAVOUKIAN is recognized as one of the leading privacy experts in the world. An avowed believer in the role that technology can play in protecting privacy, Dr. Cavoukian’s leadership has seen her office develop a number of tools and procedures to ensure that privacy is protected in Ontario – and around the world. Dr. Ann Cavoukian was appointed Ontario's Information and Privacy Commissioner in 1997, and is the first to be reappointed for a second term.

Noted for her seminal work on Privacy Enhancing Technologies in 1995, her mantra of “privacy by design” seeks to embed privacy into the design specifications of technology, thereby achieving the strongest protections.

Dr. Cavoukian’s published works include Who Knows: Safeguarding Your Privacy in a Networked World (1997), written with Don Tapscott, and, The Privacy Payoff: How Successful Businesses Build Customer Trust (2002), written with Tyler Hamilton.

Jay CROWLEY is Senior Advisor for Patient Safety in FDA's Center for Devices and Radiological Health. Jay is interested in developing new methods and techniques to identify, analyze, and understand problems occurring from medical device use within the healthcare environment. He has been working at FDA for nearly 20 years in a variety of positions. Jay holds degrees in Risk Analysis and Engineering.

11 GS1 Healthcare – Improving patient safety worldwide GS1 Healthcare Conference Toronto, Canada, 17-19 June 2008 Paul CRESSEY has joined the GS1 New Zealand Board, bringing substantial experience and knowledge of the public healthcare sector to the leadership of this organisation. Mr Cressey has been involved with the management and governance of companies and other organisations in the sector for more than 30 years.

As Chairman of the Health Information Strategy Action Committee, a Ministerial committee reporting to the Minister of Health, he was responsible for leading the promotion of the implementation of this strategy among district health boards and other healthcare providers. The strategy encompasses further standardisation of information on pharmaceuticals and other items, and greater use of ICT across the sector for operational efficiency and improved healthcare outcomes. Mr Cressey is also the Chairman of the Injury Surveillance Ministerial Advisory Panel.

A professional pharmacist, Paul has previously owned and operated pharmacy businesses. For 10 years until 2004, he was the Managing Director of East Health Services Limited. He has been a member of the member of the Counties Manukau District Health Board since 2001, and was recently re-elected.

This year, Paul was made an Officer of the New Zealand Order of Merit for services to the Child Cancer Foundation, in recognition of a 25-year contribution in this area.

Nicolas FLORIN is CEO of GS1 Switzerland since 1st July 2006. Prior to his current role, he worked for over 10 years for the Galenica Group, a diversified Group active throughout the healthcare market, from manufacturer to retailer. Nicolas first worked as financial controller of the Wholesale subsidiary Galexis and after that as Business Development Manager and later on as General Manager of the Alloga Group, a European Pre-wholesale company providing broad range of specialized logistics services to pharmaceutical manufacturers. In addition to his CEO role for GS1 Switzerland, Nicolas is representing GS1 in Europe in the Leadership Team of GS1 Healthcare.

Stephen HESS joined Merck in 1987 supporting the animal health packaging business. Since then he has worked in various Human health and vaccine packaging related positions including International and Domestic responsibilities. He is currently the Executive Director of packaging technology for Merck and Co., Inc.

Prior to joining Merck, Stephen worked at Purdue Pharma and Olin Chemical in packaging related functions. He graduated from Michigan State University with a BS in Packaging in 1980.

12 GS1 Healthcare – Improving patient safety worldwide GS1 Healthcare Conference Toronto, Canada, 17-19 June 2008 Noel HODGES is a licensed pharmacist in the Commonwealth of Virginia.

As the Director of Pharmacy Services for HCA Central Atlantic Supply Chain, he is responsible for facility supply chain pharmacy operation to identify and execute continuous improvement opportunities. Mr. Hodges completed his pharmacy degree at Purdue University and his Master of Business Administration from Strayer University. Hodges has lead the pharmacy implementation of Bed-side Point of Care (BPOC) for the HCA Richmond Division, and provides continuous monitoring of bedside scanning compliance and patient safety. He was also responsible for developing a centralize bar-code packing operation for his health-system.

He has spoken multiple times on bed-side scanning systems, drug packaging, and BPOC.

Dr. Charles JAFFE is the CEO of Health Level 7. Previously, he was the Senior Global Strategist for the Digital Health Group at Intel Corporation, Vice President of Life Sciences at SAIC and the Director of Medical Informatics at AstraZeneca Pharmaceuticals.

He completed his medical training at Johns Hopkins and Duke Universities, and was a post-doctoral fellow at the National Institutes of Health and at Georgetown University. Formerly, he was President of InforMed, an informatics consultancy for research informatics. Over his career, he has been the principal investigator for more than 200 clinical trials, and has served in various leadership roles in the American Medical Informatics Association. He has been a board member on leading organizations for information technology standards, and served as the chair of a national institutional review board. Currently he holds an appointment in the Department of Engineering at Penn State University. He has been the contributing editor for several journals and has published on a range of subjects, including clinical management, informatics deployment, and healthcare policy.

Dr. Donald JUZWISHIN is CEO of the Health Council of Canada. Dr.

Juzwishin has 28 years of leadership and management experience in health care management, policy making, education and research.

Pages:   || 2 | 3 |

Similar works:

«Women with Bleeding Disorders Judy Kauffman, RN, MS, CPNP The original chapter on Women with Bleeding Disorders for this manual was written by the late Renee Paper, RN, CCRN who was a woman with a bleeding disorder and a tireless pioneer advocate for women who bleed. Bleeding disorders affect females as well as males. Pathological bleeding in women has the potential to affect the lives of all of us, since everyone has a mother, sister, wife, or daughter, and female friends. Many healthcare...»

«INDEX Advice Guidance Signposting Finding a GP / Hospital / Dentist Page 4 Page 5 – 6 Dental Access Practices Community Dental Team Pages 7 8 Entitlement to Free Dental Treatment Page 9 -10 Finding Social Services Page 11 Page 12 – 13 Housing / Repairs/ Filling Forms / Socialising Benefits / Welfare reforms / Bedroom Tax Page 14 Page 15 – 17 Travel Vaccinations Gender Identity Clinics Page 18 Wheelchair Loans Page 19 1 Complaints Wolverhampton Health Advocacy Page 21 New Cross, West Park...»

«NOHA SHARAFELDIN MD, MSc, PhD School of Medicine Office: +1 205.638.2144 Institute for Cancer Outcomes and Survivorship Cell:+1 205.602.2172 University of Alabama at Birmingham Fax:+1 205.638.2121 Lowder 500, 1600 7th Avenue South E-mail: nsharaf@uab.edu Birmingham, AL, USA 35233-1711 EDUCATION Ph.D. in Public Health, GPA 4.0, 2014. School of Public Health, Department of Public Health Sciences, University of Alberta, Edmonton, Canada Supervisors: Prof. Yutaka Yasui, University of Alberta; Dr....»


«SIXTY-FOURTH WORLD HEALTH ASSEMBLY A64/8 5 May 2011 Provisional agenda item 13.1 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits Report by the Open-Ended Working Group of Member States on Pandemic Influenza Preparedness: sharing of influenza viruses and access to vaccines and other benefits The Director-General has the honour to transmit to the Sixty-fourth World Health Assembly the report of the Open-Ended Working Group of Member States...»

«Faculty of Health Sciences, Department of Medical Biology, Tumour Biology Research Group Oral Squamous Cell Carcinoma Role of the Plasminogen Activation System in Tumour Progression — Synnøve Norvoll Magnussen A dissertation for the degree of Philosophiae Doctor – Month 20xx Oral Squamous Cell Carcinoma (OSCC) Role of the Plasminogen Activation System in Tumour Progression Doctoral Thesis Synnøve Norvoll Magnussen Tumour Biology Research Group Department of Medical Biology Faculty of...»

«Health Select Committee inquiry: Child and Adolescent Mental Health Services Written evidence submitted by the Royal College of Paediatrics and Child Health March 2014 Introduction The RCPCH welcomes the opportunity to respond to the Health Select Committee inquiry into child and adolescent mental health services. Mental disorders in children and young people are increasing and represent a hidden epidemic. This has significant implications for society as whole, both today and in the future....»

«[.] [.] Subject: RFI ME/CFS Research HHV-6 associated mononucleosis preceding onset of ME/CFS Pathogen-induced VDR dysfunction Gut Enterovirus infection Prevalence of SIBO in ME/CFS patients; Does treatment of SIBO improve symptoms of CFS in a subset of patients?Define Subsets of patients Sore throat causes in ME/CFS patients; Is it found only in a certain subset?Nutraceuticals trial Education Include ME/CFS in Medical School Curriculum [.] [.] Subject: CFS I have had CFS for over 49 years and...»

«Posted on Public Health Website on 5/10/16 Final Comments about Thurston County OSS Management Plan The online survey was open from 10/9/15-12/15/15 and reopened from 2/2/16 – 2/18/16. Comments were also submitted via letter, e-mail, printed survey forms, and phone calls.PLAN RECOMMENDATIONS Generally supportive Septic plan recommendations are 1-not strong enough for reasonable, and 3-just right for public health. The current system is totally unreasonable and a flat rate makes much more...»

«ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.1. NAME OF THE MEDICINAL PRODUCT LEMTRADA 12 mg concentrate for solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 12 mg alemtuzumab in 1.2 ml (10 mg/ml). Alemtuzumab...»

«Safety and Health Policy and Procedure Manual COMPRESSED AIR AND GASES Section 0200 Table of Contents I. INTRODUCTION II. SCOPE III. STANDARDS IV. GENERAL REQUIREMENTS V. COMPRESSED AIR USED FOR CLEANING VI. AIR RECEIVERS VII. COMPRESSED GAS-PORTABLE CYLINDERS A. Cylinders and Containers B. Transporting and Moving of Compressed Gas Cylinders C. Storage D. Operating Procedures VIII. TRAINING Appendices A. Definitions B. Training Roster SECTION 0200 I. INTRODUCTION It is very important that those...»

«SANCO – E.2 (01)D/521667 SHORT REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH (Section Animal health and welfare) HELD IN BRUSSELS ON 08-09 OCTOBER 2002 President: Mr. Bernard Van Goethem All the Member States were present.1. EXCHANGE OF VIEWS OF THE COMMITTEE ON THE EVOLUTION OF ANIMAL DISEASES IN THE COMMUNITY INCLUDING: Classical swine fever France France gave an oral overview of the situation in the departments Moselle and Meurthe-et-Moselle. East of the A31 highway,...»

<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.